A5072525894- Cardiac Valve Diseases and Treatments
- Infective Endocarditis Diagnosis and Management
- Coronary Interventions and Diagnostics
- Cardiovascular Function and Risk Factors
- Acute Myocardial Infarction Research
- Cardiac Imaging and Diagnostics
- Atrial Fibrillation Management and Outcomes
- Aortic Disease and Treatment Approaches
- Cardiac Structural Anomalies and Repair
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiac pacing and defibrillation studies
- Health Systems, Economic Evaluations, Quality of Life
- Venous Thromboembolism Diagnosis and Management
- Antiplatelet Therapy and Cardiovascular Diseases
- Heart Failure Treatment and Management
- Mechanical Circulatory Support Devices
- COVID-19 Clinical Research Studies
- Cardiomyopathy and Myosin Studies
- Peripheral Artery Disease Management
- Cardiac Arrest and Resuscitation
- Health and Medical Research Impacts
- Cardiac Arrhythmias and Treatments
- Healthcare Policy and Management
- Global Public Health Policies and Epidemiology
- Cardiac Health and Mental Health
Franciscan Health
2022-2025
Indiana University – Purdue University Indianapolis
2022-2025
Indiana University School of Medicine
2022-2025
Indiana University
2024
Mayo Clinic in Arizona
2024
Henry Ford Hospital
2024
Thomas Jefferson University
2024
Cleveland Clinic
2019-2023
Akron General Medical Center
2019-2023
Dow University of Health Sciences
2023
The role of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB) in the setting coronavirus disease 2019 (COVID-19) pandemic is hotly debated. There have been recommendations to discontinue these medications, which are essential treatment several chronic conditions, while, absence clinical evidence, professional societies advocated their continued use.To study association between use ACEIs/ARBs with likelihood testing positive for COVID-19 outcome data...
<h3>Importance</h3> The coronavirus disease 2019 (COVID-19) pandemic has resulted in severe psychological, social, and economic stress people's lives. It is not known whether the of associated with an increase incidence cardiomyopathy. <h3>Objective</h3> To determine outcomes cardiomyopathy during COVID-19 compared before pandemic. <h3>Design, Setting, Participants</h3> This retrospective cohort study at cardiac catheterization laboratories primary percutaneous coronary intervention...
Data on the contemporary changes in risk profile and outcomes of patients undergoing percutaneous coronary intervention (PCI) or bypass grafting (CABG) are limited.To assess trends characteristics PCI CABG United States.This retrospective cohort study used a national inpatient claims-based database to identify from January 1, 2003, December 31, 2016. analysis was performed July 15 October 4, 2019.Demographic characteristics, prevalence factors, clinical presentation divided into 3 eras...
In transcatheter aortic valve replacement (TAVR) recipients, the optimal management of concomitant chronic obstructive coronary artery disease (CAD) remains unknown. Some advocate for pre-TAVR percutaneous intervention, while others manage it expectantly. The aim this study was to assess impact varying degrees and extent untreated CAD on TAVR longer-term outcomes.
Background Social and environmental factors play an important role in the rising health care burden of cardiovascular disease. The Centers for Disease Control Prevention developed Vulnerability Index (SVI) from US census data as a tool public officials to identify communities need support setting hazardous event. SVI (ranging least vulnerable score 0 most 1) ranks on 15 social including unemployment, minoritized groups status, disability, them under 4 broad themes: socioeconomic housing...
Racial and social disparities exist in outcomes related to cancer cardiovascular disease (CVD). The aim of this cross-sectional study was the impact vulnerability on mortality attributed comorbid CVD. Centers for Disease Control Prevention Wide-Ranging Online Data Epidemiologic Research database (2015-2019) used obtain county-level data cancer, CVD, County-level index (SVI) (2014-2018) were obtained from CDC’s Agency Toxic Substances Registry. SVI percentiles generated each county aggregated...
There is renewed interest in pursuing frugal and readily available laboratory markers to predict mortality readmission heart failure. We aim determine the relationship between absolute lymphocyte count (ALC) clinical outcomes patients with failure hospitalization.This was a retrospective cohort study of Patients were divided into two groups based on ALC, less than or equal 1500 cells/mm3 > cells/ mm3. The primary outcome all-cause mortality. did subgroup analysis ejection fraction studied...
With the approval of transcatheter aortic valve replacement (TAVR) for patients with severe symptomatic stenosis at intermediate surgical risk, TAVR volume is projected to increase exponentially in United States. The 30-day readmission rate was recently reported 17.9%. association between institutional and metric has not been examined. To assess hospital readmission. In this observational study, we used 2014 Nationwide Readmissions Database identify hospitals established programs (performing...
Objective We aimed to analyse the incidence of prosthesis–patient mismatch (PPM) and elevated gradients after aortic valve in (ViV), evaluate predictors associations with clinical outcomes this adverse event. Methods A total 910 ViV patients were investigated. Elevated residual defined as ≥20 mm Hg. PPM was identified based on indexed effective orifice area (EOA), measured by echocardiography, patient body mass index (BMI). Moderate severe (cases) European Association Cardiovascular Imaging...
Limited data are available regarding clinical outcomes of valve-in-valve (ViV) transcatheter aortic valve implantation (TAVI) following the United States Food and Drug Administration approval ViV TAVI in 2015.The aim this study was to evaluate in-hospital, 30-day, 6-month versus repeat surgical replacement (SAVR) patients with a failed bioprosthetic valve.This retrospective cohort identified who underwent or SAVR utilising Nationwide Readmission Database from 2016 2018. Primary were...